HPLC Methods for Semaglutide Quality Analysis: Ensuring Drug Purity and Stability | Research

The takeaway

A multimodal HPLC stability-indicating approach was developed for comprehensive semaglutide quality analysis, detecting degradation products under various stress conditions for pharmaceutical quality control.

Quality assurance
Advanced HPLC methods ensure every semaglutide batch is pure — detecting degradation that could affect safety and efficacy

What the researchers found

Multimodal HPLC stability-indicating methods: comprehensive semaglutide quality analysis identifying degradation products under thermal, photolytic, acid, base, and oxidative stress conditions.

Why it matters

Drug quality analysis ensures patient safety. With millions taking semaglutide, robust quality methods prevent degraded product from reaching patients.

How the study worked

Development and validation of multimodal HPLC methods for semaglutide stability indication, degradation product identification under ICH stress conditions.

What this study cannot tell us

Analytical method development. Applicability to all semaglutide formulations needs verification.

How to read the evidence

Analytical method development and validation.

When this study was published

Published in 2025.

The bigger picture

Quality analytical methods are the invisible backbone of pharmaceutical safety — ensuring every semaglutide dose is pure and effective.

Questions still open

Should these methods be standardized across all semaglutide manufacturers?
Do biosimilar semaglutides show the same degradation profile?
Would these methods detect counterfeit semaglutide?

Common questions

How is semaglutide quality tested?

Advanced HPLC methods measure purity and detect any degradation products. This study developed comprehensive tests that check how semaglutide breaks down under various conditions.

Does this affect my medication safety?

These quality methods ensure every batch of semaglutide you receive meets strict purity standards. They are essential for manufacturing quality control.

Read the original research

A multimodal HPLC stability indicating approach for the estimation of Semaglutide and Tirzepatide in bulk, pharmaceutical dosage forms, and rat plasma: a six-edged sustainability appraisal.

BMC chemistry, 20(1), 31

View on PubMed ↗Publisher’s paper ↗

Citation

Khalil, Hadeel A; Hassanein, Nermeen A; El-Yazbi, Amira F; Mahgoub, Hoda. (2026). A multimodal HPLC stability indicating approach for the estimation of Semaglutide and Tirzepatide in bulk, pharmaceutical dosage forms, and rat plasma: a six-edged sustainability appraisal.. BMC chemistry, 20(1), 31. https://doi.org/10.1186/s13065-025-01716-7